Starton Therapeutics Receives Authorization from the FDA to

FDA agrees to the planned Phase 1b study in second-line transplant-ineligible patients in multiple myeloma



Treatment regimen will include Velcade® and dexamethasone and replace oral... | June 12, 2023

Related Keywords

Delaware , United States , Pedro Lichtinger , Healthwell Pubco , Jamie Oliver , Drug Administration , Healthwell Acquisition Corp , Starton Therapeutics Inc , Holdings Corp , Exchange Commission , Nasdaq , Starton Therapeutics , Healthwell Acquisition , About Starton , Combination Agreement , Registration Statement , Business Combination Agreement , Merger Agreement , Annual Report , While Starton ,